The usability of ark clam shell (Anadara granosa) as precursor to produce hydroxyapatite nanoparticles via wet chemical precipitate method
This paper reported the uses of ark clam shell calcium precursor in order to form hydroxyapatite (HA) via the wet chemical precipitation method. The main objective of this research is to acquire better understanding regarding the effect of sintering temperature in the fabrication of HA. Throughout e...
Saved in:
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Springer
2015
|
Online Access: | http://psasir.upm.edu.my/id/eprint/46708/1/The%20usability%20of%20ark%20clam%20shell%20%28Anadara%20granosa%29%20as%20precursor%20to%20produce%20hydroxyapatite%20nanoparticles%20via%20wet%20chemical%20precipitate%20method.pdf http://psasir.upm.edu.my/id/eprint/46708/ http://www.springer.com/materials/journal/10853 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Universiti Putra Malaysia |
Language: | English |
Summary: | This paper reported the uses of ark clam shell calcium precursor in order to form hydroxyapatite (HA) via the wet chemical precipitation method. The main objective of this research is to acquire better understanding regarding the effect of sintering temperature in the fabrication of HA. Throughout experiment, the ratio of Ca:P were constantly controlled, between 1.67 and 2.00. The formation of HA at these ratio was confirmed by means of energy-dispersive X-ray spectroscopy analysis. In addition, the effect of sintering temperature on the formation of HA was observed using X-ray diffraction analysis, while the structural and morphology was determined by means of field emission scanning electron microscopy. The formation of HA nanoparticle was recorded (~35-69 nm) in the form of as-synthesize HA powder. The bonding compound appeared in the formation of HA was carried out using Fourier transform infrared spectroscopy such as biomaterials that are expected to find potential applications in orthopedic and biomedical industries. |
---|